Stock Analysts’ Downgrades for February 12th (ABT, ACLS, BBD, BCML, BEP, EME, FIS, FLNC, IKT, INCY)

Stock Analysts’ downgrades for Wednesday, February 12th:

Abbott Laboratories (NYSE:ABT) was downgraded by analysts at StockNews.com from a strong-buy rating to a buy rating.

Axcelis Technologies (NASDAQ:ACLS) was downgraded by analysts at William Blair from an outperform rating to a market perform rating.

Banco Bradesco (NYSE:BBD) was downgraded by analysts at The Goldman Sachs Group, Inc. from a buy rating to a sell rating. The firm currently has $2.00 target price on the stock, down from their previous target price of $2.40.

BayCom (NASDAQ:BCML) was downgraded by analysts at Hovde Group from an outperform rating to a market perform rating. Hovde Group currently has $31.00 price target on the stock.

Brookfield Renewable Partners (NYSE:BEP) (TSE:BEP) was downgraded by analysts at StockNews.com from a buy rating to a hold rating.

EMCOR Group (NYSE:EME) was downgraded by analysts at StockNews.com from a strong-buy rating to a buy rating.

Fidelity National Information Services (NYSE:FIS) was downgraded by analysts at Susquehanna from a positive rating to a neutral rating. The firm currently has $81.00 price target on the stock, down from their previous price target of $103.00.

Fluence Energy (NASDAQ:FLNC) was downgraded by analysts at Wolfe Research from an outperform rating to a peer perform rating.

Fluence Energy (NASDAQ:FLNC) was downgraded by analysts at Roth Mkm from a buy rating to a neutral rating. Roth Mkm currently has $6.50 price target on the stock, down from their previous price target of $20.00.

Fluence Energy (NASDAQ:FLNC) was downgraded by analysts at Royal Bank of Canada from an outperform rating to a sector perform rating. Royal Bank of Canada currently has $7.00 target price on the stock, down from their previous target price of $25.00.

Fluence Energy (NASDAQ:FLNC) was downgraded by analysts at UBS Group AG from a buy rating to a neutral rating. They currently have $8.00 target price on the stock, down from their previous target price of $28.00.

Inhibikase Therapeutics (NYSE:IKT) was downgraded by analysts at HC Wainwright from a buy rating to a neutral rating.

Incyte (NASDAQ:INCY) was downgraded by analysts at StockNews.com from a strong-buy rating to a buy rating.

Moleculin Biotech (NASDAQ:MBRX) was downgraded by analysts at Maxim Group from a buy rating to a hold rating.

Monarch Casino & Resort (NASDAQ:MCRI) was downgraded by analysts at StockNews.com from a strong-buy rating to a buy rating.

ON (NYSE:ONON) was downgraded by analysts at The Goldman Sachs Group, Inc. from a buy rating to a neutral rating. They currently have $57.00 target price on the stock.

OppFi (NYSE:OPFI) was downgraded by analysts at JMP Securities from an outperform rating to a market perform rating.

Onestream (NASDAQ:OS) was downgraded by analysts at JPMorgan Chase & Co. from an overweight rating to a neutral rating. They currently have $26.00 target price on the stock, down from their previous target price of $30.00.

PPG Industries (NYSE:PPG) was downgraded by analysts at JPMorgan Chase & Co. from an overweight rating to a neutral rating. JPMorgan Chase & Co. currently has $115.00 target price on the stock, down from their previous target price of $145.00.

STAAR Surgical (NASDAQ:STAA) was downgraded by analysts at William Blair from an outperform rating to a market perform rating.

STAAR Surgical (NASDAQ:STAA) was downgraded by analysts at BTIG Research from a buy rating to a neutral rating.

STAAR Surgical (NASDAQ:STAA) was downgraded by analysts at Mizuho from an outperform rating to a neutral rating. Mizuho currently has $17.00 price target on the stock, down from their previous price target of $45.00.

STAAR Surgical (NASDAQ:STAA) was downgraded by analysts at Jefferies Financial Group Inc. from a buy rating to a hold rating.

Tempus AI (NASDAQ:TEM) was downgraded by analysts at William Blair from an outperform rating to a market perform rating.

Vipshop (NYSE:VIPS) was downgraded by analysts at StockNews.com from a buy rating to a hold rating.

Woodward (NASDAQ:WWD) was downgraded by analysts at StockNews.com from a strong-buy rating to a buy rating.